Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide with Immunochemotherapy for Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
NCT06709885Phase 2Recruiting
- Start
- Oct 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in colon adenocarcinoma. Started Oct 2024; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on NCT06709885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06709885.